Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

OBJECTIVE: Topotecan, a novel topoisomerase-1 inhibitor, is a drug that appears to be effective against platinum-resistant ovarian cancers. However, the molecular mechanisms by which Topotecan treatment inhibits cancer cell proliferation are unclear. We investigated whether Topotecan increases the e...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Tsunetoh, Satoshi, Terai, Yoshito, Sasaki, Hiroshi, Tanabe, Akiko, Tanaka, Yoshimichi, Sekijima, Tatsuharu, Fujiwara, Satoe, Kawaguchi, Hiroshi, Kanemura, Masanori, Yamashita, Yoshiki, Ohmichi, Masahide
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Landes Bioscience 2010
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3047105/
https://ncbi.nlm.nih.gov/pubmed/20935474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.10.11.13443
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg